24
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Possible Benefits of High-Dose Chemotherapy as Intensive Consolidation in Patients with High-Risk Rhabdomyosarcoma Who Achieve Complete Remission with Conventional Chemotherapy

, , , , , , , & show all
Pages 201-210 | Published online: 09 Jul 2009

  • Baker KS, Anderson JR, Link MP, et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2000;18:2427-2434.
  • Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995;13:610-630.
  • Klingebiel T, Perd U, Hess CF, et al. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol. 1998;30:269-275.
  • Atra A, Pinkerton R. Autologous stem cell transplantation in solid tumours of childhood. Ann Med. 1996;28:159-164.
  • Horowitz ME, Kinsella TJ, Wexler LH, et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol. 1993;11:1911-1918.
  • Koscielniak E, Klingebiel TH, Peters C, et al. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant. 1997;19:227-231.
  • Lucidarme N, Valteau-Couanet D, Oberlin O, et al. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors. Bone Marrow Transplant. 1998;22:535-540.
  • Hara J, Osugi Y, Ohta H, et al. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors. Bone Marrow Transplant. 1998;22:7-12.
  • Ozkaynak MF, Matthay K, Cairo M, et al. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors. J Clin Oncol. 1998; 16:937-944.
  • Boulad F, Kernan NA, LaQuaglia MP, et al. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. J Clin Oncol. 1998; 16:1697-1706.
  • Carli M, Colombatti R, Oberlin O, et al. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol. 1999;17:2796-2803.
  • Eguchi H, Takaue Y: Peripheral blood stem cell autografts in the treatment of pediatric solid tumors. In: Dicke KA, Heating A, eds. Autologous Marrow and Blood Transplantation. Arlington, VA: The Cancer Treatment Research and Educational Institute; 1995:597-606.
  • Kaplan ES, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53: 457-480.
  • Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study, I: a final report Cancer. 1988;61:209-220.
  • Koscielniak E, Jurgens H, Winkler K, et al. Treatment of soft tissue sarcoma in childhood and adolescence: a report of the German Cooperative Soft Tissue Sarcoma Study. Cancer. 1992;70:2557-2567.
  • Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study, IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091-3102.
  • Perentesis J, Katsanis E, DeFor T, et al. Autologous stem cell transplantation for high-risk pediatric solid tumors. Bone Marrow Transplant. 1999;24:609-615.
  • Blay JY, Bouhour D, Ray-Coquard I, et al. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. J Clin Oncol. 2000;18:3643-3650.
  • Gadner H. Is there evidence-based benefit of autologous stem cell transplantation in children with solid tumors? Onkologie. 2002;25:278-281.
  • Weigel BJ, Breitfeld PP, Hawkins D, et al. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol. 2001;23:272-276.
  • Pappo A, Anderson JR, Grist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 1999;17:3487-3493.
  • Grupp SA, Stem JW, Bunin N, et al. Tandem high-dose therapy in rapid sequence for children with high risk neuroblastoma. J Clin Oncol. 2000;18:2567-2575.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.